November 18th, 2026White House Withdraws Heidi Overton's Nomination as FDA CommissionerThe withdrawal came on the eve of a Senate committee vote, leaving the FDA without a nominee as vaccine and mifepristone debates continue.Read more
November 18th, 2026How Peptides Are Becoming Tools for the Future of Care DeliveryDespite conflicting opinions regarding safety, experts are exploring peptides for uses that run the gamut of patients’ clinical care.Read more
November 17th, 2026Plan Churn, Claims Format Overhaul Loom for Pharmacies in 2027Owners believe clean plan-to-patient matching before January 1 is one of the simplest ways to protect cash flow in 2027.Read more
November 17th, 2026US Loses Measles Elimination Status as 2026 Cases Top 5400The PAHO confirmed the loss after more than 12 months of continuous transmission, putting renewed focus on pharmacists' role in closing vaccination gaps.Read more
November 17th, 2026DOL Finalizes PBM Transparency Rule with Implications for Employers, Independent PharmaciesNew PBM compensation disclosures and audit rights could help employers spot reimbursement practices that hurt independent pharmacies, if they act.Read more
November 16th, 2026What Pharmacists Should Know About Shifting Peptide PolicyWith patients buying gray-market peptides, HHS’s draft policy aims to reunite prescribers, patients, and pharmacists around these emerging products.Read more
November 16th, 2026Gazyva Approved as First Drug for Primary Membranous NephropathyDespite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.Read more
November 16th, 2026FDA Expands Dexmedetomidine for At-Home UseFor patients with schizophrenia or bipolar I or II disorder, dexmedetomidine use will no longer require provider supervision.Read more